Skip to main content

US ClosedU.S. Closed

Healthcare · Drug Manufacturers - General

Organon & Co. , a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies.

52W Range

100thpctl

Volume

0.42×avg

Market Cap

3.61BUSD

P/E Ratio

17.4TTM

Div Yield

0.58%ann

Loading chart data...

Current StateState loading

Organon & Co.

OGNNew York Stock Exchange·USD·Closed

Organon & Co.

OGNNew York Stock Exchange·USD·Closed

$13.76

+0.00%

$13.76

+$0.00 (0.00%)

52W Range

100thpctl

Volume

0.42×avg

Mkt Cap

3.61BUSD

P/E

17.4TTM

Div Yield

0.58%ann

OGN: Organon & Co. Stock Analysis | finqOS